Recipharm cutting jobs in Sweden; Almac expands its manufacturing tech;

> Recipharm is planning to cut about 100 jobs in its native Stockholm, looking to reduce costs. More

> A New York private equity outfit acquired a 90% stake in Italian contract drugmaker Doppel Farmaceutici. Story

> Almac has expanded its drug development services to include new processing and encapsulation technology at its U.K. hub. Item

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.